compound semaglutide fda shortage Compounded is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Compounded GLP-1 Medications May Soon
Description
Foods I used to crave stopped appealing to me

Drug Targets Ther
October 16, 2025: Rybelsus Patients Have Higher Risk of Kidney Problems Than Tirzepatide A new study has found that semaglutide drugs, like Rybelsus, are associated with a higher rate of acute kidney injury than other types of GLP-1 drugs

No Phase 3 results have been published as of May 2026
